Detomidine

Detomidine

SCHEMBL4628630

CCc1cccc(CC)c1Cc1c[nH]cn1.Cc1cccc(Cc2c[nH]cn2)c1C

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.40
HTR1A P08908 1/20 0.40
SLC6A2 P23975 2/20 0.31
SLC6A4 P31645 2/20 0.31
SLC6A3 Q01959 2/20 0.31
P2RX7 Q99572 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
KCNH2 Q12809 1/20 0.30
SCN5A Q14524 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Detomidine SCHEMBL247340 0.90 ALDH1A1 (0.35) TAAR1SLC6A2SLC6A4SLC6A3P2RX7
Detomidine SCHEMBL7087060 0.90 ALDH1A1 (0.35) TAAR1SLC6A2SLC6A4SLC6A3P2RX7
SCHEMBL2102247 0.89 TAAR1 (0.41) TAAR1HTR1ACYP1A2CYP3A4CYP2D6
Detomidine SCHEMBL28676651 0.89 ALDH1A1 (0.34) TAAR1SLC6A2SLC6A4SLC6A3P2RX7
Detomidine SCHEMBL203174 0.89 ALDH1A1 (0.34) TAAR1SLC6A2SLC6A4SLC6A3P2RX7
Detomidine SCHEMBL20362222 0.89 ALDH1A1 (0.34) TAAR1SLC6A2SLC6A4SLC6A3P2RX7
Detomidine SCHEMBL21618409 0.89 ALDH1A1 (0.34) TAAR1SLC6A2SLC6A4SLC6A3P2RX7
SCHEMBL2102304 0.89 TAAR1 (0.49) TAAR1HTR1AKCNH2SCN5A
Detomidine SCHEMBL21624996 0.87 SLC6A2 (0.33) TAAR1SLC6A2SLC6A4SLC6A3ALDH1A1
Detomidine SCHEMBL20362216 0.85 ESR1 (0.33) SLC6A2SLC6A4SLC6A3P2RX7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981880-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2008-10-22 EP disclosed
WO-2007085556-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-02 WO disclosed